BE836193A - Procede pour la preparation simultanee a partir d'un produit de departd'un concentre de globuline a, d'un complexe de prothrumbine et d'une solution de proteines du serum therapeutiquement utilisables - Google Patents

Procede pour la preparation simultanee a partir d'un produit de departd'un concentre de globuline a, d'un complexe de prothrumbine et d'une solution de proteines du serum therapeutiquement utilisables

Info

Publication number
BE836193A
BE836193A BE162379A BE162379A BE836193A BE 836193 A BE836193 A BE 836193A BE 162379 A BE162379 A BE 162379A BE 162379 A BE162379 A BE 162379A BE 836193 A BE836193 A BE 836193A
Authority
BE
Belgium
Prior art keywords
therapically
prothrumbin
globulin
useable
concentrate
Prior art date
Application number
BE162379A
Other languages
English (en)
Inventor
W Stephan
R Kotitschke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE836193A publication Critical patent/BE836193A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BE162379A 1974-12-14 1975-12-02 Procede pour la preparation simultanee a partir d'un produit de departd'un concentre de globuline a, d'un complexe de prothrumbine et d'une solution de proteines du serum therapeutiquement utilisables BE836193A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2459291A DE2459291C3 (de) 1974-12-14 1974-12-14 Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen

Publications (1)

Publication Number Publication Date
BE836193A true BE836193A (fr) 1976-04-01

Family

ID=5933473

Family Applications (1)

Application Number Title Priority Date Filing Date
BE162379A BE836193A (fr) 1974-12-14 1975-12-02 Procede pour la preparation simultanee a partir d'un produit de departd'un concentre de globuline a, d'un complexe de prothrumbine et d'une solution de proteines du serum therapeutiquement utilisables

Country Status (8)

Country Link
US (1) US4081431A (fr)
JP (1) JPS5182716A (fr)
AT (1) AT343277B (fr)
BE (1) BE836193A (fr)
DE (1) DE2459291C3 (fr)
FR (1) FR2293943A1 (fr)
GB (1) GB1519208A (fr)
NL (1) NL7514338A (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4302445A (en) * 1980-01-18 1981-11-24 Institut Merieux Method for concentrating and purifying antihemophilic factor or factor VIII
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4473647A (en) * 1981-02-27 1984-09-25 Amf Inc. Tissue culture medium
EP0081482A1 (fr) * 1981-06-18 1983-06-22 E. G. Birger Blombäck Procede de purification et de concentration du complexe de facteur viii
EP0076870B1 (fr) * 1981-10-12 1985-06-05 Armour Pharmaceutical Company Procédé de préparation de facteur antihémophilique hautement purifié
DE3247150A1 (de) * 1982-12-21 1984-06-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems
FR2573997B1 (fr) * 1984-12-03 1986-12-26 Commissariat Energie Atomique Support solide capable d'adsorber des lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que le plasma sanguin
JPS6317899A (ja) * 1986-07-09 1988-01-25 Green Cross Corp:The ハプトグロビンの精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
US4963265A (en) * 1988-05-06 1990-10-16 Applied Immunesciences, Inc. Plasma processing device with anaphylatoxin remover
WO1992015670A1 (fr) * 1991-02-28 1992-09-17 Hyclone Laboratories, Inc. Milieux de croissance cellulaire de serums bovins melanges et procedes de production
WO1999067277A1 (fr) * 1998-06-23 1999-12-29 Shanbrom Technologies, Llc Procede et dispositif permettant la production de proteines plasmatiques purifiees
US8597471B2 (en) 2010-08-19 2013-12-03 Industrial Idea Partners, Inc. Heat driven concentrator with alternate condensers
AU2014262532B2 (en) 2013-05-09 2019-08-22 Advanced Neuroregenerative Therapies, Llc G-CSF for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor

Also Published As

Publication number Publication date
FR2293943A1 (fr) 1976-07-09
JPS5516487B2 (fr) 1980-05-02
AT343277B (de) 1978-05-26
DE2459291C3 (de) 1981-06-04
US4081431A (en) 1978-03-28
NL7514338A (nl) 1976-06-16
GB1519208A (en) 1978-07-26
DE2459291B2 (de) 1979-03-15
DE2459291A1 (de) 1976-06-16
ATA939375A (de) 1977-09-15
FR2293943B1 (fr) 1979-01-19
JPS5182716A (en) 1976-07-20

Similar Documents

Publication Publication Date Title
BE836193A (fr) Procede pour la preparation simultanee a partir d'un produit de departd'un concentre de globuline a, d'un complexe de prothrumbine et d'une solution de proteines du serum therapeutiquement utilisables
CH556143A (fr) Procede de preparation d'une fraction soluble des proteines du petit lait.
BE821121A (fr) Procede de preparation d'un produit alimentaire proteique.
BE821983A (fr) Procede pour la preparation d'hydroxycholesterines
BE845918A (fr) Procede de preparation d'un concentre proteique et produit obtenu par ce procede
BE821211A (fr) Procede de preparation d'un produit alimentaire proteique.
FR2288476A1 (fr) Procede pour l'obtention d'isolats purifies de proteines
RO67194A (fr) Procede pour la preparation du 2,2,6,6-tetramethyle-4-piperydone
BE858409A (fr) Procede pour la preparation de proteines alimentaires fonctionnelles a partir de levures, et produits obtenus
BE846776A (fr) Procede pour produire des proteines mono-cellulaires
BE770438A (fr) Procede d'obtention de lactose et de proteines a partir du petit-lait
BE825446A (fr) Procede de coprecipitation de malachite et de bismuth, procede de preparation d'un complexe acetylure cuivreux a partir du coprecipite obtenu, et complexe ainsi produit
RO67193A (fr) Procede pour la preparation du 2,2,6,6-tetramethyle-4-piperydone
BE829947A (fr) Procede d'elimination des substances dissoutes a partir de liquides
FR2320062A1 (fr) Procede de preparation de produits suaves enrichis en proteines a partir du gluten de cereales
RO68649A (fr) Procede pour la preparation des 2-phenylamino-imidprocede pour la preparation des 2-phenulamino-imidazolines-(2)-substituees
RO75071A (fr) Procede pour la preparation des acides 7 betha-(d-2-amino-2-(alkylsulfonyleaminophenyle)-acetyle-amino)-3-r2-3-cephem-4-carboxyliques
BE849562A (fr) Procede de preparation de gammabutyrolactones a partir d'olefines
FR2322950A1 (fr) Procede pour produire une lisiere au bord d'un tissu
BE840450A (fr) Procede de modification chimique de substances proteiniques, moyen approprie a ce procede et procede pour la preparation de ces substances
BE788699A (fr) Procede de preparation d'une matiere particulaire a partir d'une solution
BE844614A (fr) Procede pour produire des filaments proteiques a partir d'une chair cuite
RO69817A (fr) Procede pour la preparation du n-(2-amino-3,5-dibromebenzyle)-n-methylecyclohexyleamine
FR2283150A1 (fr) Procede pour la preparation d'hydroxy-11b alkyl-18 oestranes
FR2286198A1 (fr) Procede pour la preparation d'agglomeres

Legal Events

Date Code Title Description
CN Change of patent owner's name

Owner name: *BIOTEST A.G.

Effective date: 19880114

RE Patent lapsed

Owner name: BIOTEST A.G.

Effective date: 19891231